3 Huge Red Flags From Tilray's Q1 Earnings Report

Tilray's Q1 fiscal 2027 report shows top-line growth masking deteriorating fundamentals, with cash burn jumping to $16.5 million from $1.3 million a year earlier. The cash outflow is the headline number for TLRY holders.

Revenue rose, but the growth came from acquisitions, including BrewDog, rather than the core business. Core cannabis revenue fell 13%, the weakest data point in the report. Operating expenses surged 83%, a pace that far outstrips the revenue gains and compresses the path to profitability.

Interpretation: the combination of declining organic cannabis sales and sharply higher costs suggests acquired revenue is being bought at the expense of cash flow. A roughly twelvefold increase in cash burn year over year raises questions about how long the current spending pace is sustainable. These are our read of the figures, not company guidance.

The report offers no comparable data for CGC or ACB, so any read-through to peers is speculative. Investors weighing the Canadian cannabis group should treat TLRY's organic decline as company-specific until peers report their own core cannabis trends.